| Design and synthesis of novel benzenesulfonamide containing 1, 2, 3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors R Kumar, L Vats, S Bua, CT Supuran, PK Sharma European journal of medicinal chemistry 155, 545-551, 2018 | 55 | 2018 |
| Synthesis of novel 4-functionalized 1, 5-diaryl-1, 2, 3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors L Vats, V Sharma, A Angeli, R Kumar, CT Supuran, PK Sharma European journal of medicinal chemistry 150, 678-686, 2018 | 46 | 2018 |
| Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors L Vats, R Kumar, S Bua, A Nocentini, P Gratteri, CT Supuran, PK Sharma European Journal of Medicinal Chemistry 183, 111698, 2019 | 41 | 2019 |
| Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis L Vats, K Siwach, A Angeli, P Bikal, JK Bhardwaj, CT Supuran, ... Archiv der Pharmazie 356 (2), 2200439, 2023 | 4 | 2023 |
| 1, 2, 3‐Triazole‐based esters and carboxylic acids as nonclassical carbonic anhydrase inhibitors capable of cathepsin B inhibition K Siwach, M Rani, L Vats, S Giovannuzzi, AK Paul, M Brahma, N Kumari, ... Archiv der Pharmazie 357 (3), 2300372, 2024 | 2 | 2024 |
| Keto-bridged dual triazole-linked benzenesulfonamides as potent carbonic anhydrase and cathepsin B inhibitors L Vats, P Arya, R Kumar, S Giovannuzzi, N Raghav, CT Supuran, ... Future Medicinal Chemistry 15 (20), 1843-1863, 2023 | 1 | 2023 |
| In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors V Sharma, L Vats, S Giovannuzzi, B Mohan, CT Supuran, PK Sharma Archiv der Pharmazie, e2400157, 2024 | | 2024 |
